Cargando…

Comparison of Adverse Reactions Caused by Olaparib for Different Indications

Objective: Meta-analysis of safety of Olaparib in the treatment of different indications. Methods: The databases of PubMed, The Cochrane Library, EMbase, CNKI, WanFang Data and VIP were searched by computer to collect the research on the indications and the incidence of adverse reactions caused by O...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yujing, Zhao, Shengwen, Wu, Tong, Zhang, Han
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326361/ https://www.ncbi.nlm.nih.gov/pubmed/35910367 http://dx.doi.org/10.3389/fphar.2022.968163

Ejemplares similares

Discovery of a potent olaparib–chlorambucil hybrid inhibitor of PARP1 for the treatment of cancer
por: Qin, Hongyu, et al.
Publicado: (2023)

Olaparib and advanced ovarian cancer: Summary of the past and looking into the future
por: Maiorano, Brigida Anna, et al.
Publicado: (2023)

Adverse Drug Reactions Caused by Antimicrobials Treatment for Ventilator-Associated Pneumonia
por: Shen, Shan, et al.
Publicado: (2022)

Cost-Effectiveness of Genomic Test-Directed Olaparib for Metastatic Castration-Resistant Prostate Cancer
por: Su, Dan, et al.
Publicado: (2021)

Indication and adverse event profiles of denosumab and zoledronic acid: based on U.S. FDA adverse event reporting system (FAERS)
por: Su, Si, et al.
Publicado: (2023)

Adverse reaction signals mining and hemorrhagic signals comparison of ticagrelor and clopidogrel: A pharmacovigilance study based on FAERS
por: Tang, Shu, et al.
Publicado: (2022)

A systematic review on sex differences in adverse drug reactions related to psychotropic, cardiovascular, and analgesic medications
por: Shan, Yuting, et al.
Publicado: (2023)

Genetic Polymorphisms in CYP2C19 Cause Changes in Plasma Levels and Adverse Reactions to Anlotinib in Chinese Patients With Lung Cancer
por: Tan, Tingfei, et al.
Publicado: (2022)

Pharmacogenomics and adverse drug reactions in children
por: Rieder, Michael J., et al.
Publicado: (2014)

Cost-Effectiveness Analysis of Olaparib Maintenance Treatment for Germline BRCA-Mutated Metastatic Pancreatic Cancer
por: Li, Na, et al.
Publicado: (2021)

Urgent Hospital Admissions Caused by Adverse Drug Reactions and Medication Errors—A Population-Based Study in Spain
por: Mejía, Gina, et al.
Publicado: (2020)

Research on named entity recognition of adverse drug reactions based on NLP and deep learning
por: Wei, Jianxiang, et al.
Publicado: (2023)

Adverse Drug Reactions in Pediatric Oncohematology: A Systematic Review
por: Amaro-Hosey, Kristopher, et al.
Publicado: (2022)

Pharmacists’ experiences on adverse drug reaction: 10 years later
por: Karuppannan, Mahmathi, et al.
Publicado: (2022)

Pharmacogenetic Testing for Prevention of Severe Cutaneous Adverse Drug Reactions
por: Chang, Chih-Jung, et al.
Publicado: (2020)

Adverse drug reactions in an ageing PopulaTion (ADAPT) study: Prevalence and risk factors associated with adverse drug reaction-related hospital admissions in older patients
por: Cahir, Caitriona, et al.
Publicado: (2023)

The pathogenesis, diagnosis, prevention, and treatment of CAR-T cell therapy-related adverse reactions
por: Li, Yanping, et al.
Publicado: (2022)

A 7-Years Active Pharmacovigilance Study of Adverse Drug Reactions Causing Children Admission to a Pediatric Emergency Department in Sicily
por: Nasso, Chiara, et al.
Publicado: (2020)

Cost-effectiveness analysis of olaparib as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation in china
por: Shu, Yamin, et al.
Publicado: (2022)

Severe cutaneous adverse reactions to drugs: A real-world pharmacovigilance study using the FDA Adverse Event Reporting System database
por: Li, Dongxuan, et al.
Publicado: (2023)

Reported Adverse Drug Reactions in Infants: A Nationwide Analysis in Malaysia
por: Rosli, Rosliana, et al.
Publicado: (2017)

Role of Pharmacogenetics in Adverse Drug Reactions: An Update towards Personalized Medicine
por: Micaglio, Emanuele, et al.
Publicado: (2021)

Adverse Reactions to Drugs of Special Interest in a Pediatric Oncohematology Service
por: Amaro-Hosey, Kristopher, et al.
Publicado: (2021)

The pharmacogenomics of carbamazepine-induced cutaneous adverse drug reaction in the South of Vietnam
por: Nguyen, Ai-Hoc, et al.
Publicado: (2023)

The Adverse Reactions of Lianhua Qingwen Capsule/Granule Compared With Conventional Drug in Clinical Application: A Meta-Analysis
por: Hu, Caiyun, et al.
Publicado: (2022)

Cost-effectiveness of fuzuloparib compared to routine surveillance, niraparib and olaparib for maintenance treatment of patients with germline BRCA1/2 mutation and platinum-sensitive recurrent ovarian carcinoma in China
por: Nie, Jing, et al.
Publicado: (2023)

Descriptions of Adverse Drug Reactions Are Less Informative in Forums Than in the French Pharmacovigilance Database but Provide More Unexpected Reactions
por: Karapetiantz, Pierre, et al.
Publicado: (2018)

Remifentanil for Carboprost-Induced Adverse Reactions During Cesarean Delivery Under Combined Spinal-Epidural Anesthesia
por: Wei, Chang-na, et al.
Publicado: (2020)

Model Based Evaluation of Hypersensitivity Adverse Drug Reactions to Antimicrobial Agents in Children
por: Elzagallaai, Abdelbaset A., et al.
Publicado: (2021)

The Impact of Plasma Protein Binding Characteristics and Unbound Concentration of Voriconazole on Its Adverse Drug Reactions
por: Yuan, Zi-Qing-Yun, et al.
Publicado: (2020)

Pharmacist-led olaparib follow-up service for ambulatory ovarian cancer patients: A prospective study in a tertiary specialized cancer hospital in China
por: Wang, Yanting, et al.
Publicado: (2022)

Surveillance of adverse drug reactions at an adverse drug reaction monitoring centre in Central India: a 7-year surveillance study
por: Sharma, Megha, et al.
Publicado: (2021)

The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety
por: Ekor, Martins
Publicado: (2014)

Serious Adverse Drug Reactions and Safety Signals in Children: A Nationwide Database Study
por: Vieira, Jean Mendes de Lucena, et al.
Publicado: (2020)

Adverse drug reactions of leukotriene receptor antagonists in children with asthma: a systematic review
por: Dixon, Eleanor Grace, et al.
Publicado: (2021)

Evaluation of Adverse Drug Reactions in Paediatric Patients: A Retrospective Study in Turkish Hospital
por: Khan, Zakir, et al.
Publicado: (2021)

Kunxian Capsule for Rheumatoid Arthritis: Inhibition of Inflammatory Network and Reducing Adverse Reactions Through Drug Matching
por: Tang, Yujun, et al.
Publicado: (2020)

Characteristic analysis of adverse reactions of five anti-TNFɑ agents: a descriptive analysis from WHO-VigiAccess
por: Li, Mingming, et al.
Publicado: (2023)

Adverse Drug Reactions with Drugs Used in Multiple Sclerosis: An Analysis from the Italian Pharmacovigilance Database
por: Barbieri, Maria Antonietta, et al.
Publicado: (2022)

Adverse Drug Reactions in Hospitalized Patients: Results of the FORWARD (Facilitation of Reporting in Hospital Ward) Study
por: Giardina, Claudia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8hrpgoajchpt4jlinq9jua241m